American Renal Associates Holdings, Inc. (NYSE:ARA) Files An 8-K Results of Operations and Financial Condition
Item2.02
|
Results of Operations and Financial Condition. |
On March 7, 2017, American Renal Associates Holdings, Inc. issued
a press release announcing its financial and operating results
for the quarter and year ended December 31, 2016.A copy of the
press release is furnished with this report as Exhibit 99.1 and
is incorporated by reference into this item.
As provided in General Instruction B.2 of Form 8-K, the
information in this Item 2.02 and exhibit contained in this
report shall not be deemed to be filed for purposes of Section 18
of the Securities Exchange Act of 1934, or otherwise subject to
the liabilities of that section, as amended, nor shall it be
deemed to be incorporated by reference in any filing under the
Securities Act of 1933, as amended, except as shall be expressly
set forth by specific reference in such a filing.
|
Item9.01. |
Financial Statements and Exhibits. |
(d) Exhibits.
|
Exhibit Number |
Description |
|
99.1 |
Press release, dated March 7, 2017, announcing the |
About American Renal Associates Holdings, Inc. (NYSE:ARA)
American Renal Associates Holdings, Inc. is a dialysis services provider in the United States. The Company focuses on joint venture partnerships with physicians. The Company’s segment is the ownership and operation of dialysis clinics. It provides patient care and clinical outcomes to patients suffering from the advanced stage of chronic kidney disease, known as end stage renal disease (ESRD). It operates clinics through a joint venture (JV) model, in which it partners with local nephrologists to develop, own and operate dialysis clinics. Each of its clinics is maintained as a separate joint venture in which it has the controlling interest, and its nephrologist partners and other joint venture partners have a non-controlling interest. The Company opens over 20 de novo clinics each year. The Company has owned and operated over 190 dialysis clinics in partnership with approximately 350 nephrologist partners treating over 13,000 patients in over 20 states and the District of Columbia. American Renal Associates Holdings, Inc. (NYSE:ARA) Recent Trading Information
American Renal Associates Holdings, Inc. (NYSE:ARA) closed its last trading session down -1.17 at 20.36 with 39,097 shares trading hands.